CYTOO
![Cytoo](/sites/techtransfer/files/styles/rectangle_grand_crop/public/medias/images/2021-02/Cytoo.jpg?h=ca1c6768&itok=1YlDNoQC)
CYTOO is a company specialized in target discovery and selection of therapeutic candidates for the treatment of muscle and neuromuscular disorders. The company partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
Year of creation: 2008
Line of business: CRO
Institut Curie: Behind the technology and institutional co-founder
TECHNOLOGY
CYTOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
APPLICATIONS
Biotechnologies & Pharmaceuticals.